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Abstract
The chemical system for the transformation of energy in eukaryotic mitochondria has engaged researchers for almost a cen‑
tury. This summary of four lectures on the electron transport system in mitochondria is an introduction to the mammalian 
electron transport chain for those unfamiliar with mitochondrial oxidative phosphorylation. It gives references chosen to 
reflect the history of the field and to highlight some of the recent advances in bioenergetics. The electron transport chain 
converts the energy that is released as electrons are passed to carriers of progressively higher redox potential into a proton 
gradient across the membrane that drives adenosine triphosphate (ATP) synthesis. The electron carriers include flavins, 
iron–sulfur centers, heme groups, and copper to divide the redox change from reduced nicotinamide adenine dinucleotide 
(NADH) at −320 mV to oxygen at +800 mV into steps that allow conversion and conservation of the energy released in 
three major complexes (Complexes I, III, and IV) by moving protons across the mitochondrial inner membrane. The three 
processes of proton pumping are now known after the successful determination of the structures of the large membrane 
protein complexes involved. Mitochondria and their proteins play roles not only in the production of ATP but also in cell 
survival, for which energy supply is the key.
Keywords Mitochondria · Oxidative phosphorylation · Proton gradient · Redox potential · Flavin · Heme · Iron–sulfur 
cluster · Respiratory complexes
Introduction
The chemiosmotic mechanism for ATP synthesis is key to 
aerobic energy conversion in all cells, supplying the major‑
ity of the energy required for survival, repair, growth, and 
reproduction of the organism. There is a wide diversity of 
electron transport chains across the range of lifeforms, using 
either light or metabolic energy as the input, with not only 
oxygen but also other final electron acceptors. These systems 
not only convert energy from one form (chemical or light) 
to another (ion gradient across an impermeable membrane 
and subsequently back to chemical energy in the form of 
ATP) but also allow the energy to be conserved rather than 
lost as heat. Bacteria, chloroplasts, and mitochondria trans‑
port systems use the energy that is released as electrons are 
passed to progressively higher redox potential electron car‑
riers to generate proton gradients across membranes that 
can drive ATP synthesis or transport systems. This article 
focuses on the components and mechanism of the electron 
transport chain (ETC) that supports oxidative phosphoryla‑
tion in mammalian mitochondria, a process described in all 
biochemistry textbooks, and in more advanced detail in the 
book Bioenergetics 4 by Nicholls and Ferguson [1].
Figure 1 shows the underlying principle of the chemi‑
osmotic mechanism for energy conversion from its origi‑
nal form to a hydrogen ion gradient that drives the ATP 
synthase molecular machine. It is the same in chloroplasts 
using energy from sunlight and in mitochondria using the 
chemical energy from the breakdown of sugars, proteins, and 
fats. Although controversial when first described in 1961 and 
recently republished [2], chemiosmosis was finally accepted 
as the mechanism enabling oxidative phosphorylation and 
generation of ATP. Ultimately, Peter Mitchell was awarded 
a Nobel Prize in 1978 for his innovative work.
As shown in Fig. 1, a key experiment proving that a 
hydrogen ion gradient can drive ATP synthesis was the 
incorporation of isolated ATP synthase and isolated bac‑
teriorhodopsin into artificial vesicles. Illuminating the bac‑
teriorhodopsin enabled its proton pumping, and ATP was 
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synthesized from adenosine diphosphate (ADP) and phos‑
phate [3, 4]. Just equilibrating isolated mitochondria to pH 
8.8 then adding acid to the external medium to give a pH 
of about 4.3 can generate ATP [5]. Later work showed that 
movement of organic ions such as succinate could also con‑
vert the pH gradient to a membrane potential, and using 
a bacterial system, that the membrane potential influenced 
the kinetics of ATP synthase [6]. Figure 1b shows the gen‑
eral scheme with a proton pumping apparatus generating a 
hydrogen ion gradient across a membrane impermeable to 
protons. The gradient is then dissipated through the ATP 
synthase complex, driving conformational changes that are 
transmitted through the protein to the catalytic trimer of this 
molecular machine.
Mitochondria are central to energy integration in eukary‑
otic cells. Thought to originate from endosymbiosis, each 
mitochondrion has 5–10 copies of circular DNA and a com‑
plete protein translation system in the matrix [7]. The mito‑
chondrial DNA encodes for all the RNA involved in protein 
synthesis in the matrix but also for 13 proteins that are subu‑
nits of the ETC complexes: seven subunits in Complex I, one 
in Complex III, three in Complex IV, and one in the ATP 
synthase (sometimes called complex V). To introduce the 
complexes that will be discussed, Fig. 2 shows a schematic 
representation of the oxidative phosphorylation system in 
the inner membrane of mitochondria in mammalian cells. 
Complexes I and II link metabolic oxidation in the matrix 
(the citric acid cycle and β‑oxidation) to reduction of coen‑
zyme Q (Q, ubiquinone in mammalian systems). Reduced 
Q (ubiquinol,  QH2) is reoxidized by Complex III that passes 
electrons via cytochrome c to Complex IV, the terminal 
oxidase. Electron transfer from a low redox potential donor 
to a higher redox potential acceptor in three complexes is 
coupled to proton movement from the matrix to the inter‑
membrane space (IMS) that equilibrates with the cytosol of 
the cell. These three complexes (I, III, and IV) are some‑
times called the “coupling sites” of the respiratory chain. 
The proton gradient (with the thermodynamically equivalent 
membrane potential) across the membrane drives ATP syn‑
thesis via the ATP synthase in intact coupled mitochondria. 
In the steady state, respiring mitochondria support a trans‑
membrane electrochemical gradient of around 220 mV. The 
proton motive force can be expressed as
where Δψ is the membrane potential and ΔpH is the pH 
difference across the membrane, both expressed as the cyto‑
plasmic minus the matrix values. The membrane potential 
is positive outside and the pH is lower outside than in the 
matrix.
Figure 2 also shows the consumption of dioxygen by 
mitochondria, a measure of the rate of electron transport. If 
mitochondria are uncoupled by breaking the membrane or 
by adding an uncoupler (a membrane‑permeant weak acid 
that acts to transfer protons from outside to the matrix), 
then the ETC can work at its maximum rate (Fig. 2b, left). 
Healthy mitochondria have a proton‑impermeable mem‑
brane that supports the proton gradient. These mitochon‑
dria are termed “coupled” because the passage of electrons 
along the ETC (and hence the consumption of dioxygen) 
is coupled to ATP synthesis. In coupled mitochondria, the 
Δp = Δ휓 −
(
2.3RT
F
)
ΔpH,
Fig. 1  The chemiosmotic system requires a proton pump and a mem‑
brane to generate a proton gradient and the ATP synthase (ATPase). 
a Light‑driven bacteriorhodopsin incorporated into artificial vesicles 
with the isolated ATP synthase. Illumination results in a proton gra‑
dient that drives ATP synthesis. b The proton pumping complexes 
(ETC) support the driving force, namely the proton electrochemical 
gradient Δp, which has two thermodynamically equivalent compo‑
nents: the membrane potential Δψ and the pH gradient (ΔpH)
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maximum rate of ETC, measured as oxygen consumption, 
is only observed in the presence of ADP (Fig. 2b, right). 
The respiratory control ratio (RCR) is used to define cou‑
pling: it is the ratio of the rate of oxygen consumption in 
the presence of high ADP to the rate in the presence of 
high ATP. Lower values of RCR indicate that protons leak 
through the membrane, when the energy is released as heat 
rather than conserved as ATP.
This article describes the electron transport system 
and how the movement of electrons is coupled to pro‑
ton pumping to generate the hydrogen gradient across the 
mitochondrial inner membrane. The release of energy 
from electrons passing along electron carriers from lower 
to higher potential drives proton pumping in the three key 
membrane complexes of the electron transport chain, viz. 
Complex I, Complex III, and Complex IV (Fig. 2). Enor‑
mous crystallography challenges have been overcome to 
provide the structures of the complexes. When combined 
with functional studies using spectroscopy and electron 
paramagnetic resonance (EPR) and a wealth of informa‑
tion from bacterial and plant systems, these structures sup‑
port a detailed picture of the fascinating mitochondrial 
energy‑transforming machinery.
Cofactor structures and redox potentials
The redox cofactors are held within the proteins that pro‑
vide insulation from the surrounding aqueous environ‑
ment as well as binding sites for the chemicals required 
to donate and accept electrons. The mammalian electron 
transport chain (ETC) contains the flavins, iron–sulfur 
clusters (Fe–S), several types of heme, and, in the termi‑
nal oxidase, copper (Cu), structures for which are shown in 
Figs. 3 and 4. The families of redox carriers have different 
properties that come from variants of cofactor structure 
and from the specific protein environment, as will become 
apparent from the brief description here and can be found 
in more depth in the references. 
Flavins Flavin mononucleotide (FMN) and flavin 
adenine dinucleotide (FAD), derived from the vitamin 
riboflavin in humans, can be reduced by one electron to 
the flavosemiquinone, or by two electrons to the flavohy‑
droquinone (Fig. 3). All forms can be protonated or not 
depending on the environment [8]. The redox potentials 
for the two‑electron reduction lie in the region of −0.2 V, 
but the exact redox potential is modulated by the protein: 
for example, the covalently bound FAD in beef heart Com‑
plex II (succinate dehydrogenase) has a midpoint potential 
Fig. 2  Mitochondrial oxidative 
phosphorylation. a Components 
of the electron transport system 
from NADH to oxygen that 
transfer protons from inside to 
outside the inner membrane: 
Complexes I, II, and IV. The 
 F1F0ATP synthase (complex V) 
allows proton translocation from 
outside the inner membrane 
(high  H+ concentration) to 
the matrix (low  H+) to drive 
ATP synthesis. b Oxygen 
consumption by mammalian 
mitochondria in the presence of 
pyruvate and malate that sup‑
port generation of NADH in the 
matrix. The slow rate observed 
at the start of each trace is 
called state 2 (substrate but 
no ADP). When uncoupler is 
added (left), the maximum rate 
of the ETC is observed as the 
system is no longer limited by a 
high electrochemical potential. 
When ADP is added (right), the 
ATP synthase facilitates proton 
movement into the matrix 
(state 3 rate of oxygen con‑
sumption) until all the ADP has 
been converted to ATP, when 
the rate is again limited by the 
high electrochemical potential 
(state 4 rate)
b
Time
O2
ADP
ADPUncoupler
State 4
State 3
uncoupled
a
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of −0.079 V. This also links to catalysis: electrocatalytic 
voltammetry studies demonstrated that redox poise and 
pH strongly influence the catalytic activity of succinate 
dehydrogenase, favoring succinate oxidation only above 
pH 7.7 [9].
In the ETC, Complex I (NADH‑Q oxidoreductase) con‑
tains FMN, whereas FAD is the cofactor in the non‑proton 
pumping enzymes, succinate dehydrogenase (succinate‑Q 
oxidoreductase, Complex II) in the citric acid cycle, and 
electron‑transferring flavoprotein (ETF)‑Q oxidoreductase 
that brings electrons from fatty acid oxidation. The role of 
the flavins in Complexes I and II is to transduce the two‑
electron input from NADH or succinate, respectively, to pass 
one electron down the subsequent series of one‑electron‑
carrying iron–sulfur clusters in these complexes.
Fig. 3  Cofactor structures. a 
FMN in oxidized, one‑electron‑
reduced semiquinone, and fully 
reduced forms; b Iron–sulfur 
clusters  Fe2S2 and  Fe4S4; c 
Heme (c‑type)
Fig. 4  Redox carriers in 
cytochrome oxidase (Com‑
plex IV). The binuclear  CuA 
center (brown balls; the ligands 
are detailed in the box on 
the right) accepts an electron 
from cytochrome c (red circle). 
Electrons pass to the two heme 
groups buried in the helices, 
cytochrome a (LS, low‑spin 
heme in the bottom box) and 
cytochrome a3 (HS, high‑spin 
heme), and to the  CuB that binds 
to dioxygen. (Adapted from [12] 
with permission from American 
Chemical Society Publications)
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Iron–sulfur clusters The mitochondrial respiratory chain 
contains clusters with two, three, or four iron atoms bridged 
by sulfur atoms. The 2Fe–2S and 4Fe–4S clusters shown in 
Fig. 3 are liganded to the protein via cysteine residues. Each 
cluster is reduced by only one electron, but the charge is 
unevenly distributed over the metal atoms (a mixed valence 
state). Reduced forms are detectable by electron paramag‑
netic resonance (EPR) (S = ½ for most of the ETC clusters). 
The EPR signals provided a useful tool to determine reduc‑
tion in the mitochondrial membrane in the 1960s (reviewed 
in [10]), and EPR continues to be used to examine the vari‑
ous proportions of oxidized and reduced carriers (their redox 
status) in complex systems [11].
Heme groups Cytochromes contain heme groups: iron 
surrounded by a porphyrin ring that provides four of the 
coordination sites, with the fifth and sixth coordination pro‑
vided by amino acid side‑chains, usually histidine or methio‑
nine. The different types of heme are characterized by dis‑
tinctive visible spectral changes on reduction; for example, 
the difference maxima for the two b‑type cytochromes  (b556 
and  b564) in Complex III are 556 nm and 564 nm. These two 
b cytochromes are also distinguished by electron paramag‑
netic resonance (EPR) as  bL and  bH, indicating low‑ and 
high‑spin behavior, respectively. Hemes are single‑electron 
carriers. Those found in the mammalian mitochondrial ETC 
have redox potentials above 0 mV (Table 1), with the poten‑
tial depending upon the substitutions on or puckering of the 
porphyrin ring; For example, cytochromes with methionine 
coordinating to the iron at the axial positions have potentials 
about 100 mV higher than those with histidine. In general 
terms, the redox potential is influenced by solvent exposure, 
by electrostatic interactions inside the protein, and by the 
axial ligands.
The cytochrome heme groups function to carry electrons 
from the mobile coenzyme ubiquinol (reduced from Q to 
 QH2 by Complexes I and II as described below) to dioxy‑
gen. Figure 3c shows a c‑type heme such as that found in 
cytochrome c, the mobile carrier between Complex III and 
Complex IV. The c‑type heme in cytochrome c, a small 
highly conserved protein of only about 12 kDa, has histi‑
dine as the fifth coordination site ligand to the iron atom 
and methionine as the sixth. To facilitate electron transfer, 
the cytochrome c binds to Complex III to accept an electron 
and to Complex IV to donate an electron via electrostatic 
binding, which results in the donating and accepting hemes 
being positioned close together and away from bulk solvent.
Copper centers Heme groups carry only one electron, but 
four electrons are required to reduce dioxygen to water at the 
end of the respiratory chain. This is achieved in Complex IV 
(cytochrome oxidase) using a combination of hemes and 
copper centers [binuclear copper‑A  (CuA), cytochrome a, 
cytochrome a3, and copper‑B] (Fig. 4). The  CuA center has 
two coppers with histidine and methionine and a main‑chain 
carbonyl as ligands. Although there are two coppers, the 
 CuA center accepts only one electron, which is delocalized 
across both coppers.
Major complexes and mobile carriers
The electron carriers are reduced according to the general‑
ized half‑reaction
where n is the number of electrons involved and m is the 
number of hydrogens. The midpoint potential is the potential 
at which half is oxidized and half is reduced (see [1, Chap. 
3] for a full explanation). The midpoint redox potentials of 
the electron carriers (Table 1) feed into the thermodynamic 
prediction of their order in the electron transport chain order, 
but it is not that simple. The relationship between the Gibbs 
free energy for electron transfer between two redox couples 
at pH 7 is calculated from the redox potential difference for 
their oxidation/reduction. For each of two components A 
and B:
where n is the number of electrons transferred, R is the 
gas constant, F is the Faraday constant, Eh is the midpoint 
redox potential of the half‑reaction, and ΔEh is the difference 
between the two redox potentials. In biological systems, the 
values are given for pH 7. Where protons are involved in a 
oxidized + ne− + mH ↔ reduced,
Eh = E
0 +
2.3RT
nF
log
[oxidized]
[reduced]
so ΔG = EhA − EhB = −nFΔEh,
Table 1  Midpoint potentials (pH 7) for reduction of ETC electron 
carriers. Adapted from [1]
Mobile carriers are shown in bold
a Note that Cyt  a3 and  CuB function together in a heteronuclear center 
with a redox‑active tyrosine [13]
Reductive half‑reaction E0 (mV)
2H+ + 2e− → H2 −414
NAD+ + H+ + 2e− → NADH −320
Complex I: FMN + 2H+ + 2e− → FMNH2 −300
Ubiquinone  + 2H+ + 2e− → ubiquinol 0 to +40
Rieske protein: [2Fe–2S] + e− → [2Fe–2S]− +280
Cytochrome c1: c1Fe3+ + e− → c1Fe2+ +220
Cytochrome c: cFe3+ + e− → cFe2+ +254
Binuclear  CuA +240
Cytochrome a: aFe3+ + e− → aFe2+ +290
Cytochrome a3: a3Fe3+ + e− → a3Fe2+ +550a
CuB +350a
½O2 + 2H+ + 2e− → H2O +800
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reaction, the pH changes the concentration‑dependent redox 
potential of the half‑reaction,
Considering the whole electron transport chain, the 
electron transfer from NADH (Eh = −320 mV) to quinone 
(Eh = +4 mV) under standard conditions at pH 7 would be 
associated with ΔG = −2 (0.0965 kJ mol−1  mV−1) (4 − (−
320) mV) = −62.5 kJ mol−1, being strongly energetically 
favorable and driven by a constant supply of NADH from 
cellular metabolism via the citric acid cycle (i.e., the system 
is far from equilibrium). It is important to note that, under 
physiological conditions, the proportions of oxidized and 
reduced components vary according to the metabolic condi‑
tions and the availability of oxygen, so ΔG values must be 
Eh = E
0 +
2.3RT
nF
log
[oxidized]
[reduced]
+
2.3RT
nF
log[H+].
calculated from concentration‑dependent potentials. Thus, 
reverse electron transport from Q to NADH is possible when 
the concentration of succinate is high and that of dioxy‑
gen is low. In addition to alterations in the concentration of 
reductants, the redox potential difference is modulated if 
the donor and acceptor couples are on the opposite sides of 
a membrane where there is a transmembrane potential, as 
exists across the mitochondrial inner membrane. The three 
complexes associated with electron transfer that drive proton 
movement across the membrane all have a substantial poten‑
tial difference between the donor and acceptor (NADH and 
Q, respectively, in the example above). In contrast, the ΔEh 
for succinate to Q is close to zero, so that no work can be 
done—there is no proton transfer by Complex II.
So, how was the order of the complexes shown in 
Fig. 5a and their electron carriers discovered? Early work 
Fig. 5  Demonstrating the order of electron transport complexes. a 
ETC showing substrates and inhibitors. Q in mammalian mitochon‑
dria is ubiquinone. b  O2 electrode trace for uncoupled mitochon‑
dria, showing effects of adding substrates and inhibitors in sequence. 
N,N,N′,N′‑Tetramethyl‑p‑phenylenediamine (TMPD) mediates elec‑
tron flow from ascorbate to Complex  IV. c Visible spectral changes 
after CO inhibition at cytochrome a3 reproduced from [15] with per‑
mission [copyright (2008) National Academy of Sciences]
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on beef heart mitochondria, summarized by Ernster in 
1981 [14], led to the isolation of the complexes and char‑
acterization of the cofactors in the 1950s. Key tools were 
inhibitors selective for each complex: rotenone or pierici‑
din for Complex I, thenoyltrifluoroacetone (TTFA) or car‑
boxins for Complex II, antimycin or myxothiazol for Com‑
plex III, and cyanide or carbon monoxide for Complex IV 
(Fig. 5a). These chemicals are still used in mitochondrial 
experiments today, as shown in the typical dioxygen elec‑
trode trace in Fig. 5b. Establishing the order of the car‑
riers required painstaking analysis of visible spectra (see 
Fig. 5c) and electron paramagnetic signals at poised poten‑
tials and their changes with time after inhibition or vary‑
ing dioxygen. When dioxygen was introduced to the fully 
reduced ETC, the order in which the cofactors reoxidized 
helped verify their order. Time‑resolved spectroscopy has 
been used in modern format to investigate supercomplexes 
within the ETC [15].
The organization of the electron carriers within each of 
the complexes was only fully appreciated after the determi‑
nation of crystal structures from the 1990s onwards. Com‑
plete structures were determined for Complex II with only 
four subunits (reviewed in [16]), followed by Complex III 
with 11 subunits [17] and Complex IV with 13 subunits [18]. 
Complex I, with more than 45 subunits in its mammalian 
form, many of them highly hydrophobic, was the greatest 
challenge (see below), with only shapes based on electron 
microscopy available at the turn of this century. The electron 
pathways within each complex are shown in Fig. 6.
Complex I NADH‑Q oxidoreductase is an essential com‑
ponent of energy transformations in all species, with 14 core 
subunits conserved from bacteria to primates. The crystal 
structure at 6.3 Å of the eukaryotic mitochondrial Complex I 
from Yarrowia lipolytica [19, 20] with 40 subunits (giving a 
total molecular weight of 946.5 kDa) revealed a boot‑shaped 
structure running about 180 Å along the membrane with 
the “leg” protruding into the mitochondrial matrix. It is in 
this protruding part that the electron carriers of the almost 
100‑Å‑long electron transport pathway are found, with the 
binding site for Q buried in the protein on the matrix side 
of the membrane. The crystal structure of 16 subunits of 
Complex I from Thermus thermophilus, at 3.3 Å resolution 
[21], revealed 64 transmembrane helices and 9 iron–sulfur 
clusters (Fig. 6, top left). This structure enabled a detailed 
proposal for redox‑driven proton pumping that is described 
below. The first mammalian structure at 5 Å derived from 
cryoEM and modeling [22] was for the beef mitochondrial 
Complex I with 45 subunits and 8 iron–sulfur centers, allow‑
ing correlation with earlier functional and EPR studies that 
used Complex I purified from beef tissues.
Complex II Succinate‑Q oxidoreductase has two periph‑
eral subunits containing the electron carriers and two trans‑
membrane subunits essential for reduction of Q (denoted 
as UQ in Fig. 6). The electron transport pathway (Fig. 6, 
top right) spans 50 Å, but as in Complex I, the distances 
between each carrier are short enough to allow rapid electron 
transfer. A review of the structure and function of succinate 
dehydrogenases and the closely related bacterial fumarate 
reductases gives a full description of the experiments lead‑
ing to an understanding of the function [16].
Coenzyme  Q Complexes  I and II and other redox 
enzymes, such as ETF‑Q oxidoreductase which accepts 
electrons from fatty acid metabolism, reduce Q (ubiquinone/
ubiquinol, midpoint potential +40 mV, n = 2). Many bacteria 
use menaquinone, and photosynthesis in plants uses plasto‑
quinone, variants on the mammalian ubiquinone (Q) shown 
in Fig. 6. Note the long (50 carbon) hydrophobic tail which 
keeps the Q in the membrane. If concentrations of Q in the 
membrane decrease, net electron transport is decreased.
Complex III Complex III from bovine heart was crys‑
tallized as a dimer of 2 × 240  kDa with 11 subunits in 
each monomer [17]. The first electron acceptor from the 
reduced mobile carrier ubiquinol  (QH2) is a 2Fe–2S 
center (+280 mV) in the Rieske complex that protrudes 
into the IMS. The 2Fe–2S center passes the electron to 
cytochrome c1, from where the electron exits Complex III 
to the mobile cytochrome c. However,  QH2 is a two‑electron 
donor, so Complex III oxidizes  QH2 at a pair‑splitting Q‑site 
that gives concerted one‑electron reduction of the 2Fe–2S 
center (+280 mV) and of heme  BL (−90 mV) with loss 
of two  H+ to the IMS. The latter electron passes rapidly 
(400 s−1) from heme  BL to heme  BH (+40 mV), where it 
is used to reduce Q to the semiquinone in the stabilization 
site. Stabilization of the resulting anionic semiquinone is 
achieved by a hydrogen bond to histidine and hydrophobic 
groups stacked above and below the quinone ring. The pro‑
cess is repeated with a second molecule of  QH2, resulting in 
two‑electron reduced Q in the stabilization site. The process 
is known as the Q‑cycle and results in transfer of protons 
across the membrane (see below).
In the Q‑cycle, two  H+ are taken up from the matrix 
to give  QH2, which is released. Meanwhile, each electron 
passed to the Rieske 2Fe–2S moves to the cytochrome c1 
(+240  mV at 164  s−1) and then to the mobile carrier, 
cytochrome c. Thus, although two  QH2 are oxidized, one 
 QH2 is produced in the cycle, so there is net oxidation of 
one  QH2 and reduction of two molecules of cytochrome c. 
Accompanying the electron transfer, two protons are 
absorbed from the matrix and four protons are released into 
the matrix (see below). The arrangement of the carriers and 
the two Q‑sites is shown in Fig. 6 (bottom left) [23]. Both 
hemes are in the transmembrane helical subunits, while the 
Rieske 2Fe–2S and cytochrome c1 are located on the outer 
part of the membrane. The iron to cytochrome c1 distance 
of 31.6 Å is decreased to 21.3 Å when the 2Fe–2S center 
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Fig. 6  Organization of cofactors in the complexes and the struc‑
tures of the mobile carriers. CI. Arrangement of FMN and 4Fe–4S 
and 2Fe–2S clusters in the peripheral arm of Complex  I from Yar-
rowia lipolytica [20], showing center‑to‑center (and edge‑to‑edge 
in brackets) distances between the electron carriers in angstroms. 
CII. Distances between FAD, Fe–S centers, and Q (labeled UQ) in 
Complex II. CIII. Distances between the electron carriers (Fe–S and 
heme) from Q to cytochrome  c in the Complex  III dimer. (Repro‑
duced from [23] with permission, copyright (2007) National Acad‑
emy of Sciences USA.) The round circles highlight the pair‑splitting 
site, the ovals the semiquinone stabilization sites. CIV. Cartoon of the 
arrangement of electron carriers in Complex  IV (reproduced from 
[24], with permission, copyright (2008) National Academy of Sci‑
ences USA)
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is reduced, thus decreasing the distance for onward flow of 
electrons.
Cytochrome c The mobile carrier linking Complexes III 
and IV is the small (12 kDa) highly conserved protein 
cytochrome c (Fig. 6, ribbon diagram). The heme group 
(+254 mV) is attached to the protein motif CXXCH via 
two thioether bonds, with one edge of the porphyrin ring 
exposed to the solvent. This edge is presented to the binding 
partners for electron transfer thanks to electrostatic attrac‑
tion between surface lysine residues on cytochrome c and 
spaced acidic residues on the donor and acceptor complexes. 
Cytochrome c is located on the outer face of the inner mem‑
brane in the intermembrane space. If the outer membrane 
of the mitochondria is ruptured, cytochrome c escapes into 
the cytosol. Not only does this decrease the rate of electron 
transport but it also activates caspases, degradative enzymes 
in the cytosol, and acts as a trigger for apoptosis.
Complex  IV The seven‑subunit cytochrome oxidase 
accepts four electrons in turn from cytochrome c to reduce 
dioxygen to water. The electron pathway (Fig. 6, bottom 
right) is from cytochrome c to the binuclear copper A center 
to cytochrome a, to the cytochrome a3 adjacent to copper‑B, 
about 1/3 of the way into the membrane from the IMS. When 
cytochrome a3 is reduced, dioxygen can bind to be reduced 
to peroxide and then to water (see [25] for the proposed 
mechanism) with concomitant pumping of protons.
Electron transfer rates Electron transfer must be efficient 
to maximize energy conservation and to support the rapid 
rate of ATP supply required by the organism. Direct elec‑
tron transfer from the low‑potential carriers to dioxygen 
would not only generate heat rather than conserving energy 
but would also generate reactive dioxygen species deleteri‑
ous to the cell. This “leakage” of electrons is minimized 
by the location of electron carriers inside the proteins, as 
seen in the deep Q‑sites or in the tightly oriented pairing of 
cytochrome c with its donor and acceptor complexes. The 
distance between electron carriers is important for the rate 
of electron transfer, with the rate decreasing roughly  106‑fold 
per 10 Å (see [26] for the theory supported by experimental 
observations). Looking at the distances in Fig. 5, the rates 
of electron transfer in the ETC will be around  106 s−1 for 
the 15 Å prevalent in Complex I. In Complex III, although 
the distance of 32 Å from the oxidized Rieske center to 
cytochrome  c1 would predict a rate of less than 1 s−1, the 
movement of the Fe–S center closer to cytochrome c1 upon 
reduction results in a distance of 21 Å, enabling electron 
transfer at a rate consistent with the rest of the ETC.
Recent studies on the complexes indicate close asso‑
ciation of the complexes in the mitochondrial cristae 
(reviewed in [27]). Complex I forms a supercomplex with 
Complexes III and IV, known as the respirasome, thought 
to allow more efficient electron transfer by minimizing the 
distance traveled by the mobile carriers.
Proton pumping
Each of the three complexes of the pathway from NADH 
to dioxygen has a different mechanism for converting the 
energy from electron transfer into a hydrogen ion gradient 
across the mitochondrial inner membrane (Fig. 7). Com‑
plex I has four antiporter‑like channels opened by confor‑
mational change linked to electron transfer by the redox 
state of quinone [19, 21, 28]. In Complex III, the Q‑cycle 
releases four protons from the oxidation of  2QH2 in the pair‑
splitting site into the IMS, and the concomitant protonation 
of Q being reduced at the stabilization site uses two protons 
from the matrix [29]. Complex IV has proton relay channels 
lined with acidic amino acids [30–32].
The stoichiometry of protons translocated to electrons 
(nH+/2e− stoichiometry) passing down the chain has been 
much studied. The experiments using dyes, pH electrodes, 
and the ratio of the amount of dioxygen consumed to the 
amount of ADP phosphorylated are difficult, confounded by 
proton leak and experimental limitations that contribute to 
uncertainty [33]. For the individual complexes, nH+/2e− sto‑
ichiometry can be measured using artificial electron accep‑
tors to measure the electrons and using potassium ions 
in the presence of the ionophore valinomycin to quantify 
the charge movement, interpreting results in the light of 
structural knowledge. The value for Complex I is  4H+/2e−, 
recently confirmed using a combination of experiment and 
theory [34]. Complex III releases  4H+ from  2QH2 oxidized 
at the pair‑splitting site, with  2e− passing to cytochrome c. 
The other two electrons are passed to the b‑type hemes to 
reduce Q at the semiquinone stabilizing site, where  2H+ are 
taken from the matrix. Complex IV requires two scalar pro‑
tons for each water formed but also pumps  2H+/2e−. For the 
full ETC, a stoichiometry of  10H+/2e− for NADH to dioxy‑
gen and of  6H+/2e− for succinate to dioxygen are generally 
accepted (see Nicholls & Ferguson, Bioenergetics 4 [1]). On 
the side using the electrochemical gradient to make ATP, the 
mammalian stoichiometry is 2.67H+/ATP [35].
Finally, note that not all the energy is converted to ATP, 
but instead the electrochemical gradient is applied directly to 
work for the cell homeostasis. The electrochemical gradient 
drives the export of ATP from the mitochondria, the import 
of ADP, phosphate, and other small molecules, and the accu‑
mulation of calcium ions, and is required for the import of 
proteins. If the membrane impermeability to hydrogen ions 
is breached by the addition of an uncoupler such as dinitro‑
phenol (DNP), the hydrogen ion gradient collapses and the 
ETC works at maximum rate without generating ATP but 
producing heat instead. The mitochondrial inner membrane 
does contain special proteins that can allow small rates of 
leak. These uncoupling proteins are found mainly in brown 
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fat, where they allow the production of heat especially in 
neonates and young animals [36].
Inhibition
Inhibitors acting specifically at the various Q‑sites in the 
ETC are indicated in Fig. 5, and some of their structures 
are shown in Fig. 8. In 1998, Davey et al. explored how 
much each complex had to be inhibited in order to see an 
effect on ATP generation or dioxygen consumption [37]. 
Complex I has the least spare capacity, because decreased 
ATP formation and dioxygen consumption was seen with 
only 30% inhibition by rotenone. In contrast, Complex III 
had to be inhibited by more than 80% with antimycin A, 
and complex IV by more than 75% with cyanide, before 
the rate of dioxygen consumption decreased. The low 
threshold for Complex I means that even slight inhibi‑
tion can be deleterious to the energy supply of the cell.
The smallest structure in Fig. 8 is 1‑methyl‑4‑phe‑
nylpyridinium  (MPP+), which binds at the Q‑sites of 
complex I. Produced in the brain as the oxidation prod‑
uct from the neurotoxin,  1‑methyl‑4‑phenyl‑1,2,3,6‑
tetrahydropyridine (MPTP),  MPP+ is accumulated into 
dopaminergic neurons by the dopamine reuptake car‑
rier and then again accumulated as a result of its posi‑
tive charge (a delocalized charge that does not prevent 
membrane penetration) into the mitochondrial matrix. 
Fig. 7  Three ways to pump pro‑
tons. a Complex I: four‑channel 
type opened by conformational 
change linked to electron 
transfer by the redox state of 
quinone. Adapted from Bara‑
daran et al. [21] with permission 
from Nature, copyright (2013). 
b Complex III: In the Q‑cycle, 
 4e− from  2QH2 are split to 
reduce two cytochrome c in 
the IMS, and the other  2e− are 
delivered via cytochromes bL 
and  bH to reduce Q at the matrix 
face of the membrane. The 
four protons from the  2QH2 
oxidized at the IMS surface of 
the membrane are released into 
the IMS, while the Q reduced 
at the matrix face obtains two 
protons from the matrix. c Com‑
plex IV: Proton channels (HD+ 
and HK+) conduct protons for 
the reduction of dioxygen and 
to a “proton‑loading site” for 
discharge to the outside [30]
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Fig. 8  Structures of some inhibitors of the ETC
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The amount of accumulation depends on the membrane 
potential, so that a 50 μM cytosolic concentration could 
give as much as 20 mM in the matrix [38].  MPP+ inhibits 
at two sites on complex 1, preventing electron transport, 
stopping production of ATP (without which the cell dies), 
and resulting in drug‑induced Parkinsonism [39]. Rote‑
none acts at the same site and is used as a pesticide to kill 
insects on plant crops.
Leak of electrons from the ETC to dioxygen
The electron carriers in the ETC are well insulated by 
the proteins around them, even at the Q sites, which are 
deep within the structures. Nonetheless, electrons can be 
passed from the ETC to dioxygen to generate the super‑
oxide radical (O2·−, which collects a proton at cellular pH 
to give HO2·). Superoxide, able to cross membranes only 
very slowly, is released into the matrix or cytosol, where 
it has signaling roles. The cell has strong defenses to pro‑
tect against deleterious elevated levels. The superoxide 
dismutases are copper/zinc (cytosol) or iron/manganese 
(mitochondria) containing enzymes that dismutate super‑
oxide into the less reactive (but membrane permeant) 
hydrogen peroxide  (H2O2) that is converted into water 
and dioxygen by catalase. The tripeptide antioxidant glu‑
tathione is another major defense, protecting key thiols 
in proteins, maintained in reduced state by glutathione 
reductase. The levels of glutathione in cells are used as a 
measure of oxidative stress—glutathione depletion means 
that the cell has excess reactive dioxygen species (ROS, 
shown in Fig. 9a) that damage lipids, proteins, and nucleic 
acids, damage which can eventually cause cell death.
Fig. 9  ROS species, their 
generation, and the sources of 
superoxide formation in the 
ETC. a ROS and the redox 
potentials for interconversion. b 
Haber–Weiss and Fenton reac‑
tions generate hydroxyl radical. 
c Sites of superoxide formation 
in the ETC (reprinted from 
TIBS [43] with permission from 
Elsevier)
 ChemTexts             (2019) 5:9 
1 3
   9  Page 12 of 14
As well as superoxide and hydrogen peroxide (Fig. 9a), 
the highly reactive hydroxyl radical is a potent source of 
damage to biomolecules, attacking, for example, the double 
bond in fatty acids in the membranes to form peroxides. 
The generation of hydroxyl radicals occurs in the cell in the 
presence of reduced metal ions, particularly the ubiquitous 
ferrous iron  (FeII). The Haber–Weiss reaction uses hydrogen 
peroxide and superoxide; the Fenton reaction generates the 
hydroxyl radical from hydrogen peroxide alone (Fig. 9b).
The ETC is the major source of superoxide in mammalian 
cells, mainly from the Q‑sites (Fig. 9c). Some ROS are also 
generated from the flavin sites of several dehydrogenases 
(for example, Complex I, Complex II, ETF‑Q oxidoreduc‑
tase, and pyruvate dehydrogenase) [40]. The leak of elec‑
trons from Q‑sites to dioxygen in Complex I is likely to 
come from the semiquinone moiety formed by one‑electron 
transfer from the last carrier in Complex I (Fe–S center N2). 
In Complex III, the major site is the outer, pair‑splitting site 
 Qo, located near cytochrome b556 and blocked by myxothia‑
zol. This site releases the superoxide to the cytosol. The rate 
of generation of ROS depends on the redox status of the 
ETC (recently reviewed [40]). The capacity for ROS genera‑
tion is greatest from Complex III, then Complex I, with the 
Complex II flavin contributing much less [41]. However, the 
quantities vary with redox state [42]. Under normal work‑
ing conditions in muscle mitochondria, less than 1% of the 
dioxygen turnover in the ETC results in ROS.
Cell‑based bioenergetics and concluding 
remarks
This article has presented an overview of the chemistry of 
the ETC in mammalian systems. To finish, I would like to 
point readers also to the wide diversity of ETCs across living 
systems introduced briefly with further reading in [1], and to 
the surge in medical research publications reporting meas‑
urement of bioenergetics parameters in mammalian cells.
The ability to measure bioenergetics parameters in cells 
depends on sensitive measurement of dioxygen consump‑
tion before and after carefully defined addition of first an 
ATPase inhibitor (oligomycin) to define ATP production 
in the respiring cells, then an uncoupler [carbonyl cya‑
nide‑4‑(trifluoromethoxy)phenylhydrazone (FCCP)] to 
allow maximal respiration, then inhibitors (rotenone and 
antimycin A), as shown in Fig. 10. A good description of 
the method can be found in [44], and detailed informa‑
tion and webinars about the techniques used in the Agi‑
lent Seahorse XF Analyzers are available at the Agilent 
website. The methodology has become a key technique 
for assessment of cell life and death, for cancer treatment 
development, and for understanding the complexities of 
metabolic regulation.
Bioenergetics are key to cell survival. If ATP produc‑
tion is compromised, both signaling and damage alter 
homeostasis in the cell. Mitochondria and their proteins 
play a key role not only in the production of ATP but also 
Fig. 10  Determining bioener‑
getics parameters for cells. Live 
cultured cells are incubated in a 
closed chamber to measure the 
oxygen consumption. Addition 
of the ATPase inhibitor oligo‑
mycin stops ATP production 
in the respiring cells, leaving 
the oxygen consumption rate 
due to proton leak plus the 
nonmitochondrial consump‑
tion. Addition of the uncoupler 
FCCP allows maximal respira‑
tion, then inhibitors (rotenone 
and antimycin A) to completely 
block mitochondrial oxygen use 
and take the oxygen consump‑
tion back down to nonmito‑
chondrial use only. (Figure from 
Agilent Technologies Seahorse 
XF assay, https ://www.agile 
nt.com/)
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in cell survival. The description of the ETC presented 
here provides a simple basis for further exploration of the 
mechanism of energy transduction and cell responses to 
changes in energy.
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